A Study on Etrasimod in Adults With Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately Active Ulcerative Colitis
Category & Conditions: Immune System Diseases and Conditions
Medicine: ETRASIMOD
ClinicalTrials.gov Identifier (NCT): NCT04607837
Protocol ID: C5041011 (APD334-210)
Open Plain Language Summary Result:
Click here